Athira Pharma
ATHA
ATHA
94 hedge funds and large institutions have $77.9M invested in Athira Pharma in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 98 → 94 (-4)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Holders
94
Holding in Top 10
–
Calls
$2.17M
Puts
$302K
Top Buyers
| 1 | +$2.66M | |
| 2 | +$1.54M | |
| 3 | +$454K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$417K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$322K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$722K | |
| 3 | -$601K | |
| 4 |
Renaissance Technologies
New York
|
-$484K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$273K |